Concepedia

Kristine B. Degn

KB

Statistics

Publications

6

Citations

842

H-Index

6

Active since

2004

Affiliations

Aarhus University Hospital(Current)

Novo Nordisk (Denmark)

Kristine B. Degn is an author at Aarhus University Hospital specializing in genomics, drug resistance, and host resistance.

Top concepts

Publications per year

2004–2020

6

Publications

6

One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

Kristine B. Degn, Claus Bogh Juhl, Jeppe Sturis et al. · Diabetes · 2004 · 424 citations · Full text

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

Kristine B. Degn, Birgitte Brock, Claus Bogh Juhl et al. · Diabetes · 2004 · 253 citations · Full text

Effects of the Long-Acting Human Glucagon-Like Peptide-1 Analog Liraglutide on β-Cell Function in Normal Living Conditions

Andrea Mari, Kristine B. Degn, Birgitte Brock et al. · Diabetes Care · 2007 · 83 citations · Full text

In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR<sub>120</sub>) in<i>Aspergillus fumigatus cyp51A</i>, Denmark

Rasmus Krøger Hare, Jan Berg Gertsen, Karen Marie Thyssen Astvad et al. · Emerging infectious diseases · 2019 · 54 citations · Full text

, , +17

The Insulin Secretagogues Glibenclamide and Repaglinide Do Not Influence Growth Hormone Secretion in Humans but Stimulate Glucagon Secretion during Profound Insulin Deficiency

Torben Østergård, Kristine B. Degn, Mari-Anne Gall et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 16 citations

Rows per page

1–5 of 6